CNBX Pharmaceuticals Inc.
CNBX
$0.00
$0.000.00%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.63% | 54.83% | 81.42% | 76.03% | 84.39% |
| Total Depreciation and Amortization | -- | -- | -100.00% | -100.00% | -79.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -58.93% | -83.78% | -90.92% | -93.56% | -93.10% |
| Change in Net Operating Assets | 24.86% | -22.82% | -107.67% | -50.30% | -70.65% |
| Cash from Operations | 15.12% | 29.88% | -8.89% | 28.51% | -139.37% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | 373.50% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -100.00% | 403.72% | 388.09% |
| Total Debt Issued | 421.47% | 479.71% | 43.81% | 7.24% | -73.92% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 421.47% | 479.71% | 43.81% | 7.24% | -73.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -200.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.07% | 89.05% | -304.10% | 180.19% | -207.17% |